medigraphic.com
Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autónoma de Yucatán

2021, Número 2

Siguiente >>

Rev Biomed 2021; 32 (2)


Current global situation of chagas disease

Garg NJ

Idioma: Ingles.
Referencias bibliográficas: 10
Paginas: 66-68
Archivo PDF: 447.62 Kb.


FRAGMENTO

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Aufderheide AC, Salo W, Madden M, Streitz J, Buikstra J, Guhl F, et al. A 9,000-year record of Chagas' disease. Proc Natl Acad Sci U S A 2004, 101:2034-9. doi: 10.1073/pnas.0307312101.

  2. Chagas C: Nova tripanozomiase humana: estudos sob a morfologia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., s. sp. Agente etiológico de nova entidade mórbida no homem. Mem Inst Oswaldo Cruz 1909, 1:159-218. doi.org/10.1590/S0074-02761909000200008.

  3. Lenk EJ, Redekop WK, Luyendijk M, Fitzpatrick C, Niessen L, Stolk WA, et al. Socioeconomic benefit to individuals of achieving 2020 targets for four neglected tropical diseases controlled/eliminated by innovative and intensified disease management: Human African trypanosomiasis, leprosy, visceral leishmaniasis, Chagas disease. PLoS Negl Trop Dis. 2018 Mar 13;12(3):e0006250. doi: 10.1371/journal.pntd.0006250.

  4. World Health Organization. Chagas disease: control and elimination. Report of the secretariat. WHO, Geneva, UNDP/World Bank/WHO, 2010, http://apps.who.int/gb/ ebwha/pdf_files/WHA63/A63_17-en.pdf.

  5. Basile L, Jansa JM, Carlier Y, Salamanca DD, Angheben A, Bartoloni, A et al. Working group on Chagas disease. Chagas disease in European countries: the challenge of a surveillance system. Euro Surveill. 2011;16(37):pii=19968. doi.org/10.2807/ ese.16.37.19968-en.

  6. Sanmartino M, Saavedra AA, Prat JG, Albajar-Vinas, P. Chagas and health promotion: dialogue inspired by Curitiba statement. Health Promotion International 2019, 34 (S1): i82-i91 doi.org/10.1093/heapro/day105.

  7. Coura JR, Viñas PA. Chagas disease: a new worldwide challenge. Nature 2010, 465(7301): S6-7. doi: 10.1038/ nature09221.

  8. Dias JC. Evolution of Chagas disease screening programs and control programs: historical perspective. Glob Heart. 2015, 10(3): 193-202. doi: 10.1016/j.gheart.2015.06.003.

  9. Rios L, Campos EE, Menon R, Zago MP, Garg NJ. Epidemiology and pathogenesis of maternal-fetal transmission of Trypanosoma cruzi and a case for vaccine development against congenital Chagas disease. Biochim Biophys Acta Mol Basis Dis. 2020,1866(3):165591. doi: 10.1016/j.bbadis.2019.165591.

  10. Rios LE, Vázquez-Chagoyán JC, Pacheco AO, Zago MP, Garg NJ. Immunity and vaccine development efforts against Trypanosoma cruzi. Acta Trop. 2019, 200:105168. doi: 10.1016/j.actatropica.2019.105168.




2020     |     www.medigraphic.com